Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001263987-11-000005
Filing Date
2011-12-23
Accepted
2011-12-23 15:14:33
Documents
1
Period of Report
2011-12-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6832
  Complete submission text file 0001263987-11-000005.txt   8562
Mailing Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080
Business Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080 650-244-9997 X224
VistaGen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 WEST 57TH STREET 54TH FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 54TH FLOOR NEW YORK NY 10019 212-271-7866
Platinum Long Term Growth VII, LLC (Reporting) CIK: 0001413041 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-54014 | Film No.: 111280241